ARTICLE | Company News
Ono sales and marketing update
December 19, 2011 8:00 AM UTC
Ono launched Proemend fosaprepitant dimeglumine in Japan to treat digestive symptoms resulting from the administration of antineoplastic agents. Details were not disclosed. ...